pharma · Acne Vulgaris · Plasmodium Falciparum Malaria · ATXI
AVENUE THERAPEUTICS
AVENUE THERAPEUTICS, INC.
AVENUE THERAPEUTICS clinical programs — 4 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Bay Harbor Islands, USA
- Employees
- 10
- Programs
- 4
- Drugs
- 8
- Patents
- 1
AVENUE THERAPEUTICS projects
4 ClinicalTrials.gov programs sponsored by AVENUE THERAPEUTICS.
AVENUE THERAPEUTICS has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Artemether-lumefantrine
AVENUE THERAPEUTICS, INC.
Plasmodium Falciparum Malaria
1 trial -
Tramadol
AVENUE THERAPEUTICS, INC.
Pain Management
3 trials -
Adapalene 0.003 MG/MG / Benzoyl Peroxide 0.025 MG/MG Topical Gel [Epiduo]
AVENUE THERAPEUTICS, INC.
Acne Vulgaris
1 trial -
Pyridoxal-5'-Phosphate supplement
AVENUE THERAPEUTICS, INC.
Neural Inhibition
1 trial
Frequently asked questions
How many clinical projects does AVENUE THERAPEUTICS have?
4 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.